Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer

NCT04683445 · clinicaltrials.gov ↗

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Eribulin
DRUG: Trastuzumab
DRUG: pertuzumab
DRUG: Pyrotinib
DRUG: Pembrolizumab
DRUG: Camerlizumab

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University